Greece Acts On Pharma Spending

16 June 1997

Greece has begun to carry out its promise to curb excessive spending inthe drug sector, by limiting supplies to social security fund members and reassessing the profit margins of producers, importers and pharmacists.

The government has said there will be no price rises, and even that prices could drop 16%. This would cut government spending from 584 billion drachmas ($2.11 billion) in 1996 to about 480 billion drachmas. Greece spends 50% more on medicines per capita than the European Union average.

Health Minister Costas Geitonas said doctors prescribe too many drugs and substitute cheaper products with more expensive ones, leading to constant price rises, while Deputy Social Security Minister Nikos Pharmakis says the number of drugs prescribable under social security should drop from 4,500 to 2,800.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight